Thank you for your interest in becoming a Clarity Study Investigator
Our Study Investigators play a pivotal role in Clarity’s efforts to advance innovation in science, assist healthcare professionals in providing a higher standard of care and, ultimately, improve the quality of life for patients worldwide.
To learn more, please call today to speak to a study representative or submit the form below.
PREVENT
PAIN STUDY*
(Pain Relief: Experience and Validity: Evaluating Nano Technology)
OPTIMA-G
PAIN STUDY*
(Observing Pain Transdermal Treatments-Improving and Managing All GI Symptoms)SELECT
PAIN STUDY and PMS Related Symptoms*
(Study Evaluating Real-Life Experience and Efficacy of CBD Treatment)
TAPER-P
PAIN STUDY*
(Treating Athletes in Pain: Evaluating Return to Play)IMPROVE
FOOT BATH TREATMENT*
(Identify and Monitor Patient Results: Observation of Various Foot Treatments and Evaluation)
TARGET
SCAR & BURN STUDY*
(Topical Silicone in Restoring Scars and Burn Tissue: Evaluating Therapy)
TRIPLE-A
ALLERGY STUDY*
(Assisting and Accommodating Allergy Patients)
TREAT
ALLERGY STUDY*
(Transdermal Relief: Evaluating Allergy Topicals)VISIT STUDY PAGE
Become an Investigator
To Apply to Become A Study Investigator or to Join Our Network, Please Provide the Following Information:
Areas of Research
We are currently conducting and developing clinical studies throughout the US in the following key areas:
Worldwide Recognition












Our studies continue to be recognized at leading national and international meetings. Peer reviewed articles related to our study data have been published and more are in final stages of submission
Current Studies
Study
PREVENT: “Pain Relief: Experience and Validity: Evaluating NanoTechonology” is an IRB-approved Observational Study aimed at evaluating patients’ experiences and/or perceptions and patient response for those who have received a topical Pain Patch by their clinician and those who have not. Pain management and symptoms will be evaluated by patient answers to validated pain measurement and symptom scales (e.g.; Brief Pain Inventory (BPI)and a Premenstrual Symptom Screening Scale, pending study participant group designation) as well as additional survey questions regarding patient satisfaction, patient quality of life, and resumption of their normal activities.
SELECT1 Study
SELECT is an IRB-approved Observational Study aimed at evaluating patients’ experiences and/or perceptions and patient response for those who have been prescribed a CBD tincture or topical formulation by their clinician. Pain management, Anxiety, Sleep, Gastrointestinal, and Dermatologic symptoms will be evaluated by patient answers to validated measurement scales (e.g.; Brief Pain Inventory (BPI), Gastrointestinal Quality of Life Index (GIQLI-10), The Pittsburgh Sleep Quality Index (PSQI), The Hospital Anxiety and Depression Scale (HADS), and the Acne Quality of Life Questionnaire (Acne-Qol)) as well as additional survey questions regarding patient satisfaction, current medication usage, and resumption of their normal activities.
IMPROVE Study
IMPROVE is an IRB-approved Observational Study aimed at evaluating patients’ experiences and/or perceptions and patient response for those who have been prescribed a foot bath treatment by their clinician. Data will be evaluated based on patient and provider completed questions to validated pain measurement and symptom scales (e.g.; QoL questionnaire) as well as additional survey questions regarding patient satisfaction and resumption of their normal activities.
If you are a physician or healthcare provider interested in becoming a Study Investigator for any of our current or future studies, we would like to hear from you. Please complete our online Study Investigator Application or call our dedicated Healthcare Provider HelpDesk at
1-800-616-9403.
